Related Experiment Videos
Carcinogenic effects of cytostatic protocols in CBA/Ca mice
1Department of Public Health, University Medical School of Pecs, Hungary.
In Vivo (Athens, Greece)
|January 1, 1995
Abstract:
An in vivo mouse model was developed in order to study the characteristics of secondary tumor induction by cytostatic drug combinations used in human anticancer treatment. In this model we have proved the carcino-leukemogenic effects of widely used chemotherapeutical drug combinations (CHOP, COPP, COPBLAM, VAM). The carcinogenic hazards of cyclophosphamide and other alkylating drugs could also be demonstrated in our model.